Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loewen, G.
Right arrow Articles by Mahoney, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loewen, G.
Right arrow Articles by Mahoney, M.
(Chest. 2004;125:163S-164S.)
© 2004 American College of Chest Physicians

Bimodality Lung Cancer Screening in High-Risk Patients*

A Preliminary Report

Gregory Loewen, DO, FCCP; Mary Reid, PhD; DongFeng Tan, MD; Donald Klippenstein, MD; Enriqueta Nava, MD; Raj Natarajan and Martin Mahoney, MD, PhD

* From the Department of Medicine (Dr. Loewen); Department of Cancer Prevention and Population Science (Drs. Reid and Mahoney, and Mr. Natarajan); Department of Pathology (Drs. Tan and Nava); Department of Diagnostic Radiology (Dr. Klippenstein); Roswell Park Cancer Institute, Buffalo, NY.

Correspondence to: Gregory M. Loewen, DO, FCCP, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton St, Buffalo, NY 14263; e-mail: gregory.loewen{at}roswellpark.org

It has been argued that chest radiography and sputum cytology are not adequately sensitive for the detection of early lung cancer.1 Central squamous cell lung cancers are only infrequently detected in low-dose spiral CT (LDSCT) screening studies,234 even when cytology is added to the screening protocol. The introduction of autofluorescence bronchoscopy (AF) highlighted the ability to directly visualize central squamous carcinoma in patients who are at high risk for lung cancer. In a meta-analysis of > 1,000 cases, the sensitivity of AF combined with conventional white light bronchoscopy for detection of preinvasive epithelial neoplasms was 80%.5 We hypothesized that AF combined with low-dose spiral CT (LDSCT) of the chest might be useful a screening strategy for a cohort of high-risk patients.

As a part of an ongoing prospective clinical trial of lung cancer screening, high-risk patients were offered bimodality screening (AF and LDSCT) if they had two or more of the following risk factors: (1) history of tobacco use > 20 pack-years in density, (2) history of previously treated aerodigestive tract malignancy with no evidence of disease for > 2 years, (3) asbestos-related lung disease documented by chest radiography, or (4) COPD with a measured FEV1 of < 70% predicted. All subjects underwent chest radiography, LDSCT of the chest without contrast, sputum for cytology, and AF in a single outpatient visit when possible. The end point of the trial is the detection of lung cancer. Of a projected total accrual goal of 208 patients, 121 patients have completed testing. This report summarizes the results from the first 100 patients. Accrual to this trial is ongoing.

Ninety-nine percent of the patients were current or former smokers (median age, 63 years). Forty-five percent had evidence of asbestos-related lung disease, 58% had moderate COPD, and 30% had a history of previous cancer. To date, eight intrathoracic cancers (8%) [Table 1 ] and two cases of laryngeal carcinoma in situ have been identified (median follow-up, 12 months). One interval case of advanced lung adenocarcinoma occurred in a patient with negative initial screening results; one patient with multiple pulmonary nodules (biopsy findings positive for adenocarcinoma) proved to have primary renal cell carcinoma. Chest radiography and sputum cytology did not identify any cases that were not detected by LDSCT of the chest or AF. Three of eight intrathoracic cancers (38%) of the cases were identified by bronchoscopy alone.


View this table:
[in this window]
[in a new window]

  		Table 1.. Intrathoracic Cancers Detected*

 
AF has been used as an "up-front" method of screening high-risk patients for central lung cancer in symptomatic smokers and patients with surgically cured aerodigestive tract cancers.6 AF has also been used to screen for synchronous cancer in patients with known lung cancer,78 and in patients with head and neck cancer.9 In each of these studies, occult unsuspected intraepithelial lung cancers were identified. Our preliminary results add to this literature and suggest that an aggressive approach to proactive screening with AF is feasible in a defined high-risk population, and may offer improvement in case detection over spiral CT alone.


   Footnotes
 
Abbreviations: AF = autofluorescence bronchoscopy; LDSCT = low-dose spiral CT

This research was supported in part by the Buffalo Oncologic Foundation, the Roswell Alliance, and the American Cancer Society.


   References
TOP
 References
 

  1. Petty, TL (2001) The early diagnosis of lung cancer. Dis Mon 47,204-264[CrossRef][Medline]
  2. Diederich, S, Wormanns, D, Lenzen, H, et al Screening for asymptomatic early bronchogenic carcinoma with low dose CT of the chest. Cancer 2000;89(Suppl),2483-2484[CrossRef]
  3. Henschke, CI, McCauley, DI, Yankelevitz, DF, et al Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354,99-105[CrossRef][ISI][Medline]
  4. Swensen, SJ, Jett, JR, Sloan, JA, et al Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165,508-513[Abstract/Free Full Text]
  5. Lam, S, MacAulay, C, leRiche, JC, et al Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer 2000;89(Suppl),2468-2473[CrossRef]
  6. Moro-Sibilot, D, Jeanmart, M, Lantuejoul, S, et al Cigarette smoking, preinvasive bronchial lesions, and autofluorescence bronchoscopy. Chest 2002;122,1902-1908[Abstract/Free Full Text]
  7. Paris, C, Benichou, J, Bota, S, et al Occupational and nonoccupational factors associated with high grade bronchial pre-invasive lesions. Eur Respir J 2003;21,332-344[Abstract/Free Full Text]
  8. Weigel, TL, Yousem, S, Dacic, S, et al Fluorescence bronchoscopic surveillance after curative surgical resection for non-small-cell lung cancer. Ann Surg Oncol 2000;7,176-180[Abstract]
  9. Venmans, BJ, van Boxem, TJ, Smit, EF, et al Bronchial intraepithelial neoplastic lesions in head and neck cancer patients: results of autofluorescence bronchoscopy. Ann Otol Rhinol Laryngol 2001;110,635-638[Medline]




This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loewen, G.
Right arrow Articles by Mahoney, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loewen, G.
Right arrow Articles by Mahoney, M.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS